government relations A perspective from Canada’s national health body on the future of medicine in the 21st century, from the shift to personalized medicine to streamlining regulatory and approval processes, removing duplication from international partners and utilizing modern communications technology to improve transparency and efficiency. Could you provide a brief overview of…
Generics Tom Rönnlund discusses the current state of the pharmaceutical industry in the Nordics in this time of austerity, and offers opinions on reference pricing and cooperation in the region. How have the markets in Denmark and Sweden evolves over the past five years, since the financial crisis started and austerity…
Contract Manufacturing Lilly set up in Ireland three decades ago by purchasing a farm. In its early days, the operation produced intermediaries for small-molecule drugs. Nearby, Pfizer was manufacturing citric acid for soft drinks. The country was a fledgling industrial economy that was still mostly reliant on sectors like agriculture and fishing.…
healthcare Dr. Nafsiah Mboi, who currently serves as the Minister of Health of Indonesia, has more than 40 years of experience in national and global public health, including a full career as a civil servant in the Ministry of Health and six years as Secretary of Indonesia’s National AIDS Commission. She…
Phytohealth Phytohealth is a trailbalzer in the Taiwanese biotech industry: the first publically-listed biopharma company in the country, and the first company to receive NDA approval for a Botanical New Drug. What was the vision behind this business? Phytohealth was founded in 1998. Its original purpose was to develop an extract…
diabetes Carlos Manuel González Parra discusses the progress Novo Nordisk has made as a newcomer to the Colombian market and its hopes and intentions for the future. One of the main focuses is in manoeuvring Novo Nordisk Colombia into a position where they will be a key player in the diabetes…
Country Report Our last report was in 2009-2010 when the “social emergency crisis” happened. What would you say have been the most important changes in the health system since that time? The main cause of the crisis was a drastic increase in the number of recobros (individuals asking to be reimbursed for…
IMS Health Ireland Mr. Egan, what path led you to IMS Health? My original background is in science—I received a PhD in medical microbiology, and worked for some time as a post-doctoral researcher for a Swedish biotech company that was contracting research services here in Ireland. I have since hung up my lab…
Aldimed As a means of introduction, could you please describe the origins of ALDIMED, how it started, its development the past couple of years and where it stands today? ALDIMED represents the medical technology industry in Latin America; this is a Colombian initiative and one of its founders. The Executive Board…
Pharmachemical Ireland Mr. Moran, can you please begin with a brief introduction to Pharmachemical Ireland, its mission, and how it works to achieve its goals? Pharmachemical Ireland (PCI) is an industry association representing the pharmaceutical, chemical, and biopharmaceutical manufacturing sectors in Ireland. Our raison d’être is to ensure that the regulatory…
Herba Chemosan You have been the CEO of Herba Chemosan since 2002. What were the initial goals you set for yourself when you took up this position, and where do we find Herba Chemosan today? Herba Chemosan was founded in 1916 as a cooperative for pharmacists and has undergone many transformations over…
Clonmel Healthcare Mr. Hanlon, can you please begin by introducing Clonmel Healthcare to our readers? Clonmel Healthcare was founded by an Irish family in the 1970’s. During this time, its primary goal was exporting medicines to third world countries. We were the first company in Ireland to become involved in generics. We…
See our Cookie Privacy Policy Here
